A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer

BACKGROUND: The clinical behavior of prostate cancer (PCa) is variable, and while the majority of cases remain indolent, 10% of patients progress to deadly forms of the disease. Current clinical predictors used at the time of diagnosis have limitations to accurately establish progression risk. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Georgescu, Constantin, Corbin, Joshua M., Thibivilliers, Sandra, Webb, Zachary D., Zhao, Yan D., Koster, Jan, Fung, Kar-Ming, Asch, Adam S., Wren, Jonathan D., Ruiz-Echevarría, Maria J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503380/
https://www.ncbi.nlm.nih.gov/pubmed/31060542
http://dx.doi.org/10.1186/s12885-019-5592-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503380/
https://www.ncbi.nlm.nih.gov/pubmed/31060542
http://dx.doi.org/10.1186/s12885-019-5592-6

Ejemplares similares